Calidi Bio - CLDI Quarterly Revenue Growth

Corporate company logo of Calidi Bio (CLDI)

Geopolitical instability and sanctions are disrupting biomaterial logistics, hindering the global tests of Calidi Biotherapeutics (CLDI). The company's prospects rely on the success of the NeuroNova platform in treating solid tumors and partnerships with pharmaceutical behemoths. However, liquidity shortages and high R&D costs are creating financial pressure. The quarterly revenue growth rate reflects the business dynamics, where the parameter value reaches 0.00.

CLDI (Calidi Bio) Sales Growth QoQ history from 02/21/2024 to 11/20/2026

Analytical breakdowns for Calidi Bio (CLDI)

- current quotes and average value forecast:
Fundamental company valuation:Calidi Biotherapeutics (CLDI)
Flagship merchandise of Calidi Biotherapeutics Inc.

Calidi Biotherapeutics (CLDI) is developing innovative oncolytic virotherapy, utilizing stem cells to bypass the immune barrier when destroying tumors. The daily recalculated quarterly revenue change metric allows investors to instantly detect deviations in actual cash flows from market expectations, which is critical for assessing the commercialization of the unique virus delivery technology and determining the fundamental stability of the biotech asset.

Competitors of Calidi Biotherapeutics

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Ascentage Pharma Group International (AAPG)|Revenue Growth QoQ CG Oncology, Inc.|Quarterly Revenue Growth Rate UroGen Pharma Corp URGN|Quarterly Revenue Growth BCAX|Personalis, Inc. - Sales Growth QoQ|Erasca - Quarterly Sales Growth|Quarterly Revenue Increase DCTH|YMAB: Quarterly Sales Growth|Quarterly Revenue Growth Rate Aura Corp|CADL: Quarterly Revenue Growth|ARAY - Quarterly Sales Growth Rate|SLS (SELLAS Life Sciences Group, Inc.) - Quarterly Revenue Growth|ACTU: Quarterly Revenue Increase|Revenue Growth QoQ citiusonc.com (CTOR)|Quarterly Sales Growth Rate TuHURA Biosciences|Revenue Growth QoQ Protara Therapeutics TARA|Fate Therapeutics (FATE) - Quarterly Revenue Growth Rate|WHWK - Revenue Growth QoQ|Quarterly Revenue Growth Rate TScan Therapeutics Inc|championsoncology.com (CSBR) - Revenue Growth QoQ|Sales Growth QoQ XBIT|Quarterly Sales Growth CVM|Sales Growth QoQ OSTX (OS Therapies Incorporated)|Quarterly Revenue Growth RADX|ARTV: Revenue Dynamics QoQ|Quarterly Revenue Growth ANL (Adlai Nortye Ltd)|VERU - Quarterly Sales Growth|tempesttx.com - Quarterly Revenue Growth|Quarterly Revenue Increase XLO (xiliotx.com)|RENB: Quarterly Revenue Growth|Quarterly Sales Growth Mural Oncology plc|Revenue Growth QoQ Kairos Pharma Inc|OKUR: Quarterly Revenue Increase|Quarterly Revenue Growth GDTC|CRIS (Curis) - Quarterly Revenue Increase|Revenue Growth QoQ apollomicsinc.com APLM|THAR: Sales Growth QoQ|advanbiomed.com - Quarterly Revenue Growth|Quarterly Revenue Increase GNPX (Genprex, Inc)|SBFM: Quarterly Revenue Growth|Quarterly Sales Growth Xenetic Biosciences Inc.|Revenue Growth QoQ Salarius Pharmaceuticals Inc|PPBT: Quarterly Revenue Increase|Quarterly Revenue Growth AONC|BGNE (BeOne Medicines) - Quarterly Revenue Increase|Checkpoint Therapeutics, Inc - Quarterly Sales Growth|elevationoncology.com (ELEV) - Quarterly Revenue Growth Rate|iCAD Inc. - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Ikena Oncology|NTBL: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)